Search

Author/Creator Turner, P. Kellie

1. A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma. Issue 13 (26th March 2014)

Authors:
Hamid, Omid; Ilaria, Robert; Garbe, Claus; Wolter, Pascal; Maio, Michele; Hutson, Thomas E.; Arance, Ana; Lorigan, Paul; Lee, Jeeyun; Hauschild, Axel; Mohr, Peter; Hahka‐Kemppinen, Marjo; Kaiser, Christopher; Turner, P. Kellie; Conti, Ilaria; Grob, Jean‐Jacques
Journal:
Cancer
Issue:
Volume 120:Issue 13(2014)
Page Start:
2016
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A randomized, open‐label clinical trial of tasisulam sodium versus paclitaxel as second‐line treatment in patients with metastatic melanoma. Issue 13 (26th March 2014)

Authors:
Hamid, Omid; Ilaria, Robert; Garbe, Claus; Wolter, Pascal; Maio, Michele; Hutson, Thomas E.; Arance, Ana; Lorigan, Paul; Lee, Jeeyun; Hauschild, Axel; Mohr, Peter; Hahka‐Kemppinen, Marjo; Kaiser, Christopher; Turner, P. Kellie; Conti, Ilaria; Grob, Jean‐Jacques
Journal:
Cancer
Issue:
Volume 120:Issue 13(2014)
Page Start:
2016
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials. Issue 6 (1st May 2021)

Authors:
Toi, Masakazu; Inoue, Kenichi; Masuda, Norikazu; Iwata, Hiroji; Sohn, Joohyuk; Hae Park, In; Im, Seock‐Ah; Chen, Shin‐Cheh; Enatsu, Sotaro; Turner, P. Kellie; André, Valérie A. M.; Hardebeck, Molly C.; Sakaguchi, Sachi; Goetz, Matthew P.; Sledge, George W.
Journal:
Cancer science
Issue:
Volume 112:Issue 6(2021)
Page Start:
2381
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate. Issue 5 (30th December 2018)

Authors:
Chappell, Jill C.; Turner, P. Kellie; Pak, Y. Anne; Bacon, James; Chiang, Alan Y.; Royalty, Jane; Hall, Stephen D.; Kulanthaivel, Palaniappan; Bonventre, Joseph V.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 105:Issue 5(2019)
Page Start:
1187
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Development and Application of a Mechanistic Population Modeling Approach to Describe Abemaciclib Pharmacokinetics. (13th August 2020)

Authors:
Chigutsa, Emmanuel; Kambhampati, Siva Rama Prasad; Karen Sykes, Amanda; Posada, Maria M.; van der Walt, Jan‐Stefan; Turner, P. Kellie
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 9:Number 9(2020)
Page Start:
523
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling. (20th February 2020)

Authors:
Posada, Maria M.; Morse, Bridget L.; Turner, P. Kellie; Kulanthaivel, Palaniappan; Hall, Stephen D.; Dickinson, Gemma L.
Journal:
Journal of clinical pharmacology
Issue:
Volume 60:Number 7(2020)
Page Start:
915
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗